Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - NET CHANGE IN CASH
Net Change in Cash HALO - Halozyme Therapeutics, Inc.
-116 M
LAST VALUE
-100.34%
2 YEAR CAGR
-0.98%
5 YEAR CAGR
-4.89%
10 YEAR CAGR